Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 154

1.

Regulation of osteoblast differentiation by osteocytes cultured on sclerostin antibody conjugated TiO2 nanotube array.

Chen M, Hu Y, Li M, Chen M, Shen X, Luo Z, Mu C, Yang W, Liu P, Cai K.

Colloids Surf B Biointerfaces. 2019 Mar 1;175:663-670. doi: 10.1016/j.colsurfb.2018.12.023. Epub 2018 Dec 12.

PMID:
30590327
2.

Gene variants of osteoprotegerin, estrogen-, calcitonin- and vitamin D-receptor genes and serum markers of bone metabolism in patients with Gaucher disease type 1.

Zimmermann A, Popp RA, Rossmann H, Bucerzan S, Nascu I, Leucuta D, Weber MM, Grigorescu-Sido P.

Ther Clin Risk Manag. 2018 Oct 24;14:2069-2080. doi: 10.2147/TCRM.S177480. eCollection 2018.

3.

Thy-1 Deficiency Augments Bone Loss in Obesity by Affecting Bone Formation and Resorption.

Picke AK, Campbell GM, Schmidt FN, Busse B, Rauner M, Simon JC, Anderegg U, Hofbauer LC, Saalbach A.

Front Cell Dev Biol. 2018 Oct 2;6:127. doi: 10.3389/fcell.2018.00127. eCollection 2018.

4.

Salidroside Improves Bone Histomorphology and Prevents Bone Loss in Ovariectomized Diabetic Rats by Upregulating the OPG/RANKL Ratio.

Zheng H, Qi S, Chen C.

Molecules. 2018 Sep 19;23(9). pii: E2398. doi: 10.3390/molecules23092398.

5.

Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts.

Lee DW, Kwon JY, Kim HK, Lee HJ, Kim ES, Kim HJ, Kim HJ, Lee HB.

Int J Med Sci. 2018 May 14;15(7):723-729. doi: 10.7150/ijms.22713. eCollection 2018.

6.

Hemorrhagic shock alters fracture callus composition and activates the IL6 and RANKL/OPG pathway in mice.

Bundkirchen K, Macke C, Angrisani N, Schäck LM, Noack S, Fehr M, Krettek C, Neunaber C.

J Trauma Acute Care Surg. 2018 Aug;85(2):359-366. doi: 10.1097/TA.0000000000001952.

PMID:
29787542
7.

Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.

Liu F, Tan F, Tong W, Fan Q, Ye S, Lu S, Teng Z, Han M, Zhang M, Chai Y.

Biomed Pharmacother. 2018 Jul;103:1052-1060. doi: 10.1016/j.biopha.2018.04.102. Epub 2018 Apr 25.

PMID:
29710663
8.

Acquired resistance to pamidronate treated effectively with zoledronate in juvenile Paget's disease.

Gonc EN, Ozon A, Buyukyilmaz G, Alikasifoglu A, Simsek OP, Kandemir N.

Osteoporos Int. 2018 Jun;29(6):1471-1474. doi: 10.1007/s00198-018-4443-7. Epub 2018 Mar 3.

PMID:
29502293
9.

Low-level laser therapy (780 nm) combined with collagen sponge scaffold promotes repair of rat cranial critical-size defects and increases TGF-β, FGF-2, OPG/RANK and osteocalcin expression.

de Oliveira LSS, de Araújo AA, de Araújo Júnior RF, Barboza CAG, Borges BCD, da Silva JSP.

Int J Exp Pathol. 2017 Apr;98(2):75-85. doi: 10.1111/iep.12226. Epub 2017 May 29.

10.

Autoantibodies to Osteoprotegerin are Associated with Low Hip Bone Mineral Density and History of Fractures in Axial Spondyloarthritis: A Cross-Sectional Observational Study.

Hauser B, Zhao S, Visconti MR, Riches PL, Fraser WD, Piec I, Goodson NJ, Ralston SH.

Calcif Tissue Int. 2017 Oct;101(4):375-383. doi: 10.1007/s00223-017-0291-2. Epub 2017 May 22.

11.

Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture.

Bolamperti S, Villa I, Spinello A, Manfredini G, Mrak E, Mezzadri U, Ometti M, Fraschini G, Guidobono F, Rubinacci A.

Biomed Res Int. 2016;2016:8169614. doi: 10.1155/2016/8169614. Epub 2016 Nov 24.

12.

Uremic Serum Impairs Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stromal Cells.

Della Bella E, Pagani S, Giavaresi G, Capelli I, Comai G, Donadei C, Cappuccilli M, La Manna G, Fini M.

J Cell Physiol. 2017 Aug;232(8):2201-2209. doi: 10.1002/jcp.25732. Epub 2017 Mar 1.

PMID:
27976811
13.

Bone fracture healing is delayed in splenectomic rats.

Xiao W, Hu Z, Li T, Li J.

Life Sci. 2017 Mar 15;173:55-61. doi: 10.1016/j.lfs.2016.12.005. Epub 2016 Dec 10.

PMID:
27956350
14.

Loss of Functional Osteoprotegerin: More Than a Skeletal Problem.

Grasemann C, Unger N, Hövel M, Arweiler-Harbeck D, Herrmann R, Schündeln MM, Müller O, Schweiger B, Lausch E, Meissner T, Kiewert C, Hauffa BP, Shaw NJ.

J Clin Endocrinol Metab. 2017 Jan 1;102(1):210-219. doi: 10.1210/jc.2016-2905.

PMID:
27809640
15.

Inflammatory Bowel Disease in a Rodent Model Alters Osteocyte Protein Levels Controlling Bone Turnover.

Metzger CE, Narayanan A, Zawieja DC, Bloomfield SA.

J Bone Miner Res. 2017 Apr;32(4):802-813. doi: 10.1002/jbmr.3027. Epub 2017 Feb 28.

16.

Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin.

Sato AY, Cregor M, Delgado-Calle J, Condon KW, Allen MR, Peacock M, Plotkin LI, Bellido T.

J Bone Miner Res. 2016 Oct;31(10):1791-1802. doi: 10.1002/jbmr.2869. Epub 2016 Jun 5.

17.

Vitamins D3 and K2 may partially counterbalance the detrimental effects of pentosidine in ex vivo human osteoblasts.

Sanguineti R, Monacelli F, Parodi A, Furfaro AL, Borghi R, Pacini D, Pronzato MA, Odetti P, Molfetta L, Traverso N.

J Biol Regul Homeost Agents. 2016 Jul-Sep;30(3):713-726.

PMID:
27655488
18.

Elevated ferritin and circulating osteoprotegerin levels as independent predictors of hip fracture in postmenopausal women admitted for fragility fracture: time for new screening strategies?

Lipovetzki Y, Zandman-Goddard G, Feldbrin Z, Shargorodsky M.

Immunol Res. 2017 Feb;65(1):423-427. doi: 10.1007/s12026-016-8849-z.

PMID:
27503623
19.

Novel Genetic Variants Associated With Increased Vertebral Volumetric BMD, Reduced Vertebral Fracture Risk, and Increased Expression of SLC1A3 and EPHB2.

Nielson CM, Liu CT, Smith AV, Ackert-Bicknell CL, Reppe S, Jakobsdottir J, Wassel C, Register TC, Oei L, Alonso N, Oei EH, Parimi N, Samelson EJ, Nalls MA, Zmuda J, Lang T, Bouxsein M, Latourelle J, Claussnitzer M, Siggeirsdottir K, Srikanth P, Lorentzen E, Vandenput L, Langefeld C, Raffield L, Terry G, Cox AJ, Allison MA, Criqui MH, Bowden D, Ikram MA, Mellström D, Karlsson MK, Carr J, Budoff M, Phillips C, Cupples LA, Chou WC, Myers RH, Ralston SH, Gautvik KM, Cawthon PM, Cummings S, Karasik D, Rivadeneira F, Gudnason V, Orwoll ES, Harris TB, Ohlsson C, Kiel DP, Hsu YH.

J Bone Miner Res. 2016 Dec;31(12):2085-2097. doi: 10.1002/jbmr.2913. Epub 2016 Sep 6.

20.

Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.

Piemontese M, Xiong J, Fujiwara Y, Thostenson JD, O'Brien CA.

Am J Physiol Endocrinol Metab. 2016 Sep 1;311(3):E587-93. doi: 10.1152/ajpendo.00219.2016. Epub 2016 Jul 26.

Supplemental Content

Loading ...
Support Center